ADAPTIVE BIOTECHNOLOGIES CORPORATION Amortization of Intangible Assets
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Amortization of Intangible Assets of $423.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for the quarter ending 2026-06-30 was $423.00K, a 0.00% change year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for the quarter ending 2026-03-31 was $419.00K, a 0.00% change year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for the quarter ending 2025-12-31 was $429.00K, a 0.23% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for the quarter ending 2025-09-30 was $428.00K, a 0.00% change year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for fiscal 2025 was $1.70M, a 0.23% decline from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for fiscal 2024 was $1.70M, a 0.24% increase from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for fiscal 2023 was $1.70M, a 0.00% change from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION amortization of intangible assets for fiscal 2022 was $1.70M, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $423.00K 10-Q · filed 2026-08-04 | $842.00K 10-Q · filed 2026-08-04 | $1.27M derived: sum of 3 quarters · filed 2026-08-04 | $1.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $419.00K 10-Q · filed 2026-05-05 | $848.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.28M derived: sum of 3 quarters · filed 2026-05-05 | $1.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $857.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.28M derived: sum of 3 quarters · filed 2026-08-04 | $1.70M 10-K · filed 2026-02-26 |
| 2025-09-30 | $428.00K 10-Q · filed 2025-11-05 | $851.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.27M 10-Q · filed 2025-11-05 | $1.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $423.00K 10-Q · filed 2026-08-04 | $842.00K 10-Q · filed 2026-08-04 | $1.27M derived: sum of 3 quarters · filed 2026-08-04 | $1.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $419.00K 10-Q · filed 2026-05-05 | $847.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.27M derived: sum of 3 quarters · filed 2026-05-05 | $1.70M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $856.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.28M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $428.00K 10-Q · filed 2025-11-05 | $852.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.27M 10-Q · filed 2025-11-05 | $1.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $424.00K 10-Q · filed 2025-08-05 | $847.00K 10-Q · filed 2025-08-05 | $1.28M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $423.00K 10-Q · filed 2025-05-01 | $852.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.28M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $857.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.28M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $428.00K 10-Q · filed 2024-11-07 | $851.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.27M 10-Q · filed 2024-11-07 | $1.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $423.00K 10-Q · filed 2024-08-01 | $842.00K 10-Q · filed 2024-08-01 | $1.27M derived: sum of 3 quarters · filed 2025-03-03 | $1.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $419.00K 10-Q · filed 2024-05-07 | $848.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.28M derived: sum of 3 quarters · filed 2025-03-03 | $1.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $857.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.28M derived: sum of 3 quarters · filed 2025-03-03 | $1.70M 10-K · filed 2025-03-03 |
| 2022-09-30 | $428.00K 10-Q · filed 2023-11-09 | $851.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.27M 10-Q · filed 2023-11-09 | $1.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $423.00K 10-Q · filed 2023-08-02 | $842.00K 10-Q · filed 2023-08-02 | $1.27M derived: sum of 3 quarters · filed 2024-02-29 | $1.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $419.00K 10-Q · filed 2023-05-03 | $848.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.28M derived: sum of 3 quarters · filed 2024-02-29 | $1.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $857.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.28M derived: sum of 3 quarters · filed 2024-02-29 | $1.70M 10-K · filed 2024-02-29 |
| 2021-09-30 | $428.00K 10-Q · filed 2022-11-03 | $851.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.27M 10-Q · filed 2022-11-03 | $1.70M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $423.00K 10-Q · filed 2022-08-03 | $842.00K 10-Q · filed 2022-08-03 | $1.27M derived: sum of 3 quarters · filed 2023-02-14 | $1.70M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $419.00K 10-Q · filed 2022-05-04 | $847.00K derived: sum of 2 quarters · filed 2023-02-14 | $1.27M derived: sum of 3 quarters · filed 2023-02-14 | $1.70M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $856.00K derived: sum of 2 quarters · filed 2023-02-14 | $1.28M derived: sum of 3 quarters · filed 2023-02-14 | $1.70M 10-K · filed 2023-02-14 |
| 2020-09-30 | $428.00K 10-Q · filed 2021-11-03 | $851.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.27M 10-Q · filed 2021-11-03 | $1.70M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $423.00K 10-Q · filed 2021-08-04 | $847.00K 10-Q · filed 2021-08-04 | $1.27M derived: sum of 3 quarters · filed 2022-02-15 | $1.70M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $424.00K 10-Q · filed 2021-05-05 | $852.00K derived: sum of 2 quarters · filed 2022-02-15 | $1.28M derived: sum of 3 quarters · filed 2022-02-15 | $1.70M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $856.00K derived: sum of 2 quarters · filed 2022-02-15 | $1.28M derived: sum of 3 quarters · filed 2022-02-15 | $1.70M 10-K · filed 2022-02-15 |
| 2019-09-30 | $428.00K 10-Q · filed 2020-11-10 | $851.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.27M 10-Q · filed 2020-11-10 | $1.70M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $423.00K 10-Q · filed 2020-08-10 | $842.00K 10-Q · filed 2020-08-10 | $1.27M derived: sum of 3 quarters · filed 2021-02-24 | $1.70M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $419.00K 10-Q · filed 2020-05-12 | $847.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.27M derived: sum of 3 quarters · filed 2021-02-24 | $1.70M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $856.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.28M derived: sum of 3 quarters · filed 2021-02-24 | $1.70M 10-K · filed 2021-02-24 |
| 2018-09-30 | $428.00K 10-Q · filed 2019-11-12 | $852.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.27M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $424.00K 10-Q · filed 2019-08-13 | $843.00K 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $1.69M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |